Yoon Jennifer J, Green William Ross, Kim Sinae, Kearney Thomas, Haffty Bruce G, Eladoumikdachi Firas, Goyal Sharad
Department of Radiation Oncology, New Brunswick, New Jersey.
Biometrics Division, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
Adv Radiat Oncol. 2016 Sep 21;1(4):205-215. doi: 10.1016/j.adro.2016.09.002. eCollection 2016 Oct-Dec.
Breast-conserving therapy (BCT), or breast-conserving surgery with adjuvant radiation therapy, has become a standard treatment alternative to mastectomy for women with early-stage breast cancer after many long-term studies have reported comparable rates of overall survival and local control. Oncoplastic breast surgery in the setting of BCT consists of various techniques that allow for an excision with a wider margin and a simultaneous enhancement of cosmetic sequelae, making it an ideal breast cancer surgery. Because of the parenchymal rearrangement that is routinely involved in oncoplastic techniques, however, the targeted tissue can be relocated, thus posing a challenge to localize the tumor bed for radiation planning. The goals of this systematic review are to address the challenges, outcomes, and cosmesis of oncoplastic breast surgery in the setting of BCT.
保乳治疗(BCT),即保乳手术加辅助放疗,在多项长期研究报告了总体生存率和局部控制率相当之后,已成为早期乳腺癌女性乳房切除术的标准替代治疗方法。保乳治疗背景下的肿瘤整形乳房手术包括各种技术,这些技术允许进行更宽切缘的切除并同时改善美容效果,使其成为理想的乳腺癌手术。然而,由于肿瘤整形技术通常涉及实质重新排列,目标组织可能会重新定位,从而给放射治疗计划中肿瘤床的定位带来挑战。本系统评价的目的是探讨保乳治疗背景下肿瘤整形乳房手术的挑战、结果和美容效果。